Adipocyte STAT5 deficiency promotes adiposity and impairs lipid mobilisation in mice

Doris Kaltenecker1,2, Kristina M Mueller1,2, Pia Benedikt3

  • 1Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria.

Diabetologia
|November 19, 2016
PubMed
Abstract

Insights

STAT5 in white adipose tissue is crucial for lipid metabolism. Its deficiency improves glucose metabolism but impairs lipid handling, suggesting STAT5 as a therapeutic target for metabolic diseases.

Area of Science:

  • Adipose tissue biology
  • Metabolic regulation
  • Signal transduction pathways

Background:

  • Dysfunctional lipid metabolism in white adipose tissue contributes to obesity and metabolic diseases.
  • The Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway plays a role in adipocyte function.
  • The specific role of STAT5 in white adipose tissue lipid metabolism remains unclear.

Purpose of the Study:

  • To investigate the function of STAT5 in adipocytes concerning lipid metabolism.
  • To understand how STAT5 influences metabolic homeostasis in white adipose tissue.

Main Methods:

  • Generation of adipocyte-specific Stat5 knockout mice using Adipoq-Cre.
  • In vivo and in vitro biochemical and molecular analyses were performed.

Main Results:

  • Adipocyte-specific Stat5 deletion led to increased adiposity but decreased insulin resistance and gluconeogenic capacity.
  • STAT5 deficiency reduced basal lipolysis and fasting-induced lipid mobilization.
  • Reduced levels of adipose triglyceride lipase (ATGL) and its coactivator CGI-58 were observed.
  • A functional STAT5 response element in the Pnpla2 promoter indicated transcriptional regulation by STAT5.

Conclusions:

  • STAT5 plays an essential role in maintaining lipid homeostasis in white adipose tissue.
  • STAT5 manipulation could be a potential strategy for improving metabolic disease outcomes.

Related Concept Videos